King's College London

Research portal

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)

Research output: Contribution to journalArticlepeer-review

Liona C. Poon, Laura A. Magee, Stefan Verlohren, Andrew Shennan, Peter von Dadelszen, Eyal Sheiner, Eran Hadar, Gerard Visser, Fabricio Da Silva Costa, Anil Kapur, Fionnuala McAuliffe, Amala Nazareth, Muna Tahlak, Anne B. Kihara, Hema Divakar, H. David McIntyre, Vincenzo Berghella, Huixia Yang, Roberto Romero, Kypros H. Nicolaides & 2 more Nir Melamed, Moshe Hod

Original languageEnglish
Pages (from-to)3-31
Number of pages29
JournalInternational Journal of Gynecology and Obstetrics
Issue numberS1
PublishedJul 2021

Bibliographical note

Funding Information: This project was funded by unrestricted educational grants from PerkinElmer Inc., Waltham, USA; Roche Diagnostics International Ltd, Rotkreuz, Switzerland; and Thermo Fisher Scientific, Hennigsdorf, Germany. Funding Information: Relating to the submitted work, Liona Poon reports receipt of a Health and Medical Research Fund grant to assess the role of pro‐ and antiangiogenic markers for pre‐eclampsia in the second and third trimester (Project No: 136168059), and a grant from Roche Diagnostics for the Asia PROGNOSIS study. Outside the submitted work, LP reports honoraria for lectures from Roche Diagnostics, Ferring Pharmaceuticals, and GE Healthcare; nonfinancial support of in‐kind contributions for research from Roche Diagnostics, PerkinElmer Inc., Thermo Fisher Scientific, and GE Healthcare, and personal fees for consultancy from Roche Diagnostics and Ferring Pharmaceuticals. Outside the submitted work, Stefan Verlohren reports personal fees from Roche Diagnostics, Thermo Fisher Scientific, and Alexion. Outside the submitted work, Fabricio da Silva Costa reports research support from PerkinElmer Inc., and personal fees from Roche Diagnostics and Thermo Fisher Scientific. Outside the submitted work, Kypros H. Nicolaides reports being Director of the Fetal Medicine Foundation. All other authors report no actual or potential conflicts of interest. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454